University of Alabama Hospital | ClinicalTrials HQ

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, erythropoietic protoporphyria, hepatic porphyria, hereditary disease, hereditary skin disorder, liver disorder, metabolic disease, porphyria, skin disorder	Enrolling by invitation	Phase 2 / Phase 3	2026-10-09		NCT05883748
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis	Arterial Occlusive Diseases, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, stroke disorder, vascular disorder	Active, not recruiting	Phase 3	2026-10-08		NCT05047172
Strategy for Improving Stroke Treatment Response	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 2	2026-10-02		NCT05948566
Tube Size Randomized Trial During Emergency Tracheal Intubation	Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure	Enrolling by invitation	Not applicable	2026-09-09		NCT06939361
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2	Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder	Recruiting	Phase 3	2026-08-20		NCT07227246
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes	Stress Disorders, Traumatic, acute respiratory failure, acute stress disorder, post-traumatic stress disorder, psychiatric disorder	Enrolling by invitation	Not stated	2026-08-20		NCT06179485
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Not stated	2026-07-16		NCT05907629
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma	High-risk Large B-cell Lymphoma (LBCL)	Active, not recruiting	Phase 3	2026-04-15		NCT05605899
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial	Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder	Active, not recruiting	Phase 3	2026-01-21		NCT03496883
Screening for AL Amyloidosis in Smoldering Multiple Myeloma	Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, hematologic disorder, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, precancerous condition, proteostasis deficiencies, smoldering plasma cell myeloma	Recruiting	Not stated	2025-08-06		NCT06365060